Impact of pathologic complete response on disease-free survival in patients with esophagogastric adenocarcinoma receiving preoperative docetaxel-based chemotherapy.

@article{Lorenzen2013ImpactOP,
  title={Impact of pathologic complete response on disease-free survival in patients with esophagogastric adenocarcinoma receiving preoperative docetaxel-based chemotherapy.},
  author={Sylvie Lorenzen and Peter C. Thuss-Patience and S.-E. Al-Batran and Florian Lordick and Bernhard Haller and Tibor Schuster and Claudia Pauligk and Kim Barbara Luley and Dmitry Bichev and G Schumacher and Nils Homann},
  journal={Annals of oncology : official journal of the European Society for Medical Oncology},
  year={2013},
  volume={24 8},
  pages={
          2068-73
        }
}
BACKGROUND The aim of this study was to evaluate the impact of pathologic complete response (pCR) on outcome in patients with gastric or esophagogastric junction (EGJ) adenocarcinoma after neoadjuvant docetaxel/platin/fluoropyrimidine-based chemotherapy. PATIENTS AND METHODS Patients received at least one cycle of chemotherapy for potentially operable disease. Pretreatment clinicopathologic factors and pCR were investigated. Disease-free survival (DFS), overall survival (OS) and tumor-related… CONTINUE READING

Citations

Publications citing this paper.
SHOWING 1-10 OF 38 CITATIONS

Pathological assessment of resection specimens after neoadjuvant therapy for metastatic melanoma.

  • Annals of oncology : official journal of the European Society for Medical Oncology
  • 2018
VIEW 1 EXCERPT
CITES BACKGROUND

References

Publications referenced by this paper.
SHOWING 1-10 OF 21 REFERENCES

TNM Classification of Malignant Tumors, 6th edition

LH Sobin, Wittekind Ch eds
  • 2002
VIEW 3 EXCERPTS
HIGHLY INFLUENTIAL